Journal of Experimental Therapeutics and Oncology

Aims & Scope

Journal of Experimental Therapeutics and Oncology is devoted to the rapid publication of innovative preclinical investigations on therapeutic agents against cancer and pertinent findings of experimental and clinical oncology.

In the journal you will find review articles, original articles, and short communications on all areas of cancer research, including but not limited to preclinical experimental therapeutics; anticancer drug development; cancer biochemistry; biotechnology; carcinogenesis; cancer cytogenetics; clinical oncology; cytokine biology; epidemiology; molecular biology; pathology; pharmacology; tumor cell biology; and experimental oncology.

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Andrographolide, a potential cancer therapeutic agent isolated from <i>Andrographis paniculata</i>

  Citation: 247

  Authors: Sriram, R. Ajaya, Dhanvanthri S., Chitkala, R.

• Epigallocatechin‐3‐gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR‐related pathways of signal transduction

  Citation: 192

  Authors: Muneyuki, Masumi, Jin T. E., Atsuko, Jae‐Won, I. Bernard

• A phase I trial of Depsipeptide (FR901228) in patients with advanced cancer

  Citation: 170

  Authors: John L., Naiyer, John, William, Manuela, Min H., William D., Irving, Christoff, Megan, Michael J.

• Discovery and development of anticancer agents from plants

  Citation: 54

  Authors: Fred, Charles K., Joseph, Halina, Joseph, Meide, Steve

• siRNA agents inhibit oncogene expression and attenuate human tumor cell growth

  Citation: 52

  Authors: James Q., Jingsong, Ronguang, Wang‐Ni, Jianping, Yinsheng

• Inhibition of indoleamine 2,3‐dioxygenase suppresses NK cell activity and accelerates tumor growth

  Citation: 43

  Authors: Seiichiro, Shigeru, Kouichirou, Atsushi, Katsunori, Seigo

• Local administration of IL‐12–transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice

  Citation: 39

  Authors: Yuji, Clemens, Andrea, Galina V., Zoya R., Paul D., Simon C., Satoru, Ronald B., Michael T., Michael R.

• Antitumor effect of stilbenoids from <i>Vateria indica</i> against allografted sarcoma S‐180 in animal model

  Citation: 35

  Authors: Satoshi, Kenji, Yoshihiro, Yoko, Tetsuro, Toshiyuki, Munekazu, Yoshinori, Yukihiro

• Murine pharmacokinetics and metabolism of oleandrin, a cytotoxic component of <i>Nerium oleander</i>

  Citation: 34

  Authors: Dan, Timothy L., Mary, Edward, Dah H., Robert A.

• Chronomics*^â€: circadian and circaseptan timing of radiotherapy, drugs, calories, perhaps nutriceuticals and beyond

  Citation: 33

  Authors: Franz, Germaine, Zhengrong, Chaomin, Waldemar, George, Ranjana, R.K., Rajesh Kumar, B.D., R.B., Adarsh, Eugene, Robert B., Gundu, Madan L.B., Madhu, Gulshan, Subhash, Atanu Kumar, Panchanan, Francine, Julia, Othild, Earl